Foodlaw-Reading

Dr David Jukes, The University of Reading, UK

Report of the 40th Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses

A copy of the report can be downloaded from the Codex website (click on image)

Responsible Party

Purpose

Text/Topic

Code

Step

Para.

CCEXEC77 CAC42

Adoption

Review of the Standard for Follow-up Formula: Proposed draft Essential composition requirements for older infants 

CXS 1561987

5

57 and App.III

CAC42 CCFA

Revocation

provisions for monosodium tartrate (INS 335(i)), monopotassium tartrate (INS 336(i)) and dipotassium tartrate (INS 336(ii)) in the Standard for Processed Cereal-Based Foods for Infants and Young Children 

CXS 741981

-

10

CCEXEC77 CAC42

Discontinuation

NRV-NCD for EPA and DHA long chain omega-3 fatty acids

CXG 2 – 1985

-

94

CCNFSDU41 CCNFSDU41

Hold

Review of the Standard for Follow-up Formula:  Essential composition requirements for follow-up formula for older infants and [product] for young children

CX 1561987

7

33 and App. II

Discussion

Review of the Standard for Follow-up Formula: Product definition and labelling for [product] for young children:  

4

57 and App. IV

Discussion

  Proposed draft Guideline for Ready-to-Use Therapeutic Foods

-

4

75b) and App. V

Hold

Defn for biofortification

-

4

84 and App. VI

Hold

Claim for “free” of trans fatty acids 

4

111 and App. VII

Canada

Discussion

Risk management possibilities for the reduction of TFAs

-

-

CCFL45

Endorsement /  Advice

i) Review of the Standard for Follow-up Formula: labelling provision for follow-up formula for older infants (Section A); ii) definition for biofortification

CX 1561987

-

57 and App. III; and 

-

4

84 and App. VI

CCFL45 and CCFO26

Information

Claim for “free” of trans fatty acids / risk management possibilities for reduction of TFAs

-

-

110

CCMAS40

Endorsement / Revocation

Methods for Vitamin K, folic acid and nine minerals and trace elements (infant formula and foods for special medical purposes intended for infants)

CXS 234 – 1999

-

157 and App. IX

EWG (New Zealand, France, Indonesia) CCNFSDU41

Drafting

Review of the Standard for Follow up Formula: [product] for young children (i) footnote 4 (Carbohydrate) proposal for DE for product not based on milk protein and proposal for section 3.2.1 (optional ingredients) (ii) remaining sections of the Standard

CXS 1561987

2/3

33, 57  and App. II

EWG  (South Africa, Senegal and Uganda) CCNFSDU41

Redrafting

Proposed draft guideline for ready-to-use therapeutic foods: section 5.2.2 (food additives) and section 6.2 (proteins)

-

2/3

75a) 

EWG  (Ireland, Costa Rica, and United States of America) CCNFSDU41

Discussion

NRV-R for older infants and young children

-

-

122

PWG (European Union and the Russian Federation) CCNFSDU41

Redrafting

Mechanism / framework for considering the technological justification of food additives

-

-

139 and App. VIII

CCNFSDU41

Discussion Alignment of food additives 

CXS 53-1981; 72-1981; 73-198; 74-1981; 118-1979; 156- 1987; 181-1991; 203-1995

-

140 - 141

Argentina CCNFSDU41

Discussion

Harmonized probiotic guidelines for use in foods and dietary supplements

-

-

145

Costa Rica and Paraguay CCNFSDU40

Discussion

General guidelines on nutrient profiles

-

-

154

Host country (Germany)  CCNFSDU41

Discussion

Prioritization mechanism to better manage the work of CCNFSDU

-

-

159